Charles River Laboratories International Aktie
WKN: 939391 / ISIN: US1598641074
14.02.2024 13:49:51
|
Charles River Laboratories Q4 Results, Outlook Above Street View; Shares UP In Pre-market
(RTTNews) - Charles River Laboratories International, Inc. (CRL) Wednesday posted fourth-quarter results above analysts' view. The company's full-year profit outlook also came in above the consensus estimates.
Fourth-quarter net income was $187.1 million or $3.62 per share, a decrease from $187.4 million or $3.65 per share for the same period last year.
Excluding special items, earnings were $127.2 million or $2.46 per share, that beat the average estimate of analysts polled by Thomson-Reuters of $2.40 per share. Analysts' estimates typically exclude special items.
For the quarter, revenue was $1.01 billion, a decrease of 7.9% from $1.10 billion in the previous-year quarter. The consensus estimate was for $991.25 million.
For fiscal 2024, Charles River Lab expects profit per share to be in the range of $10.90 - $11.40. Analysts see earnings of $10.79 per share for the full year. Revenue is expected to grow 1.0 percent - 4.0 percent for the year. The Street expects 3.20 percent growth in revenue.
Shares of Charles River Laboratories are up more than 4 percent in pre-market trading. The stock had closed at $220.24, down 2.45 percent on Tuesday. It has been trading in the range of 161.65 - 257.18 in the last 1 year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
22.04.25 |
Erste Schätzungen: Charles River Laboratories International präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net) | |
21.04.25 |
S&P 500-Wert Charles River Laboratories International-Aktie: So viel Verlust hätte ein Charles River Laboratories International-Investment von vor 5 Jahren eingebracht (finanzen.at) | |
21.04.25 |
Schwacher Handel in New York: S&P 500 zum Start leichter (finanzen.at) | |
14.04.25 |
Börse New York: S&P 500 letztendlich in Grün (finanzen.at) | |
14.04.25 |
Starker Wochentag in New York: S&P 500 notiert am Nachmittag im Plus (finanzen.at) | |
14.04.25 |
NYSE-Handel: S&P 500 mittags stärker (finanzen.at) | |
14.04.25 |
S&P 500-Titel Charles River Laboratories International-Aktie: So viel Verlust hätte eine Charles River Laboratories International-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
11.04.25 |
NYSE-Handel: S&P 500 verbucht am Mittag Gewinne (finanzen.at) |
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
Charles River Laboratories International Inc. | 100,80 | -0,30% |
|